Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Alopecia | 2 | 2024 | 416 | 1.250 |
Why?
|
Spondylosis | 2 | 2017 | 85 | 1.060 |
Why?
|
Negotiating | 2 | 2024 | 152 | 1.020 |
Why?
|
Surgicenters | 1 | 2024 | 37 | 0.950 |
Why?
|
Minoxidil | 1 | 2024 | 35 | 0.900 |
Why?
|
Spinal Cord Diseases | 2 | 2017 | 291 | 0.900 |
Why?
|
Oropharyngeal Neoplasms | 2 | 2019 | 493 | 0.890 |
Why?
|
Spinal Cord Neoplasms | 2 | 2016 | 263 | 0.890 |
Why?
|
Aerosols | 3 | 2021 | 634 | 0.870 |
Why?
|
Head and Neck Neoplasms | 6 | 2019 | 2930 | 0.850 |
Why?
|
Finasteride | 1 | 2024 | 86 | 0.850 |
Why?
|
Cervical Vertebrae | 3 | 2017 | 979 | 0.790 |
Why?
|
Medicare | 9 | 2023 | 6809 | 0.760 |
Why?
|
Platelet-Rich Plasma | 1 | 2024 | 180 | 0.740 |
Why?
|
Reimbursement, Incentive | 3 | 2021 | 541 | 0.740 |
Why?
|
Medicare Part B | 1 | 2022 | 116 | 0.730 |
Why?
|
Carcinoma, Squamous Cell | 5 | 2019 | 4050 | 0.700 |
Why?
|
Hypoglossal Nerve | 2 | 2022 | 110 | 0.660 |
Why?
|
X-Linked Inhibitor of Apoptosis Protein | 1 | 2019 | 61 | 0.650 |
Why?
|
Otolaryngology | 4 | 2020 | 699 | 0.650 |
Why?
|
Otorhinolaryngologic Surgical Procedures | 5 | 2020 | 325 | 0.630 |
Why?
|
Spinal Fractures | 2 | 2015 | 710 | 0.630 |
Why?
|
Financial Management | 1 | 2020 | 161 | 0.630 |
Why?
|
Cochlear Implantation | 1 | 2023 | 317 | 0.620 |
Why?
|
Hospital Charges | 1 | 2020 | 347 | 0.620 |
Why?
|
Inhibitor of Apoptosis Proteins | 1 | 2019 | 200 | 0.610 |
Why?
|
Cochlear Implants | 1 | 2023 | 342 | 0.600 |
Why?
|
Electric Stimulation Therapy | 2 | 2022 | 635 | 0.570 |
Why?
|
Neck Dissection | 1 | 2019 | 201 | 0.570 |
Why?
|
Paranasal Sinus Neoplasms | 1 | 2019 | 243 | 0.560 |
Why?
|
Outsourced Services | 1 | 2016 | 20 | 0.550 |
Why?
|
Neurosurgical Procedures | 3 | 2018 | 2076 | 0.550 |
Why?
|
Quality of Life | 9 | 2023 | 13489 | 0.540 |
Why?
|
Surgery, Plastic | 1 | 2023 | 652 | 0.530 |
Why?
|
Carcinoma, Adenoid Cystic | 1 | 2019 | 263 | 0.520 |
Why?
|
Morpholines | 1 | 2019 | 584 | 0.520 |
Why?
|
Tracheostomy | 1 | 2020 | 430 | 0.520 |
Why?
|
Specialties, Surgical | 1 | 2020 | 391 | 0.510 |
Why?
|
Thoracic Vertebrae | 2 | 2017 | 613 | 0.490 |
Why?
|
Facial Paralysis | 3 | 2023 | 346 | 0.480 |
Why?
|
Disease Transmission, Infectious | 1 | 2020 | 560 | 0.470 |
Why?
|
Disclosure | 1 | 2020 | 755 | 0.470 |
Why?
|
Decompression, Surgical | 2 | 2016 | 603 | 0.460 |
Why?
|
Endoscopy | 3 | 2020 | 1854 | 0.430 |
Why?
|
Lumbar Vertebrae | 3 | 2017 | 1885 | 0.430 |
Why?
|
Thrombospondins | 3 | 2020 | 196 | 0.420 |
Why?
|
Pyrroles | 1 | 2019 | 1123 | 0.420 |
Why?
|
Parkinson Disease | 2 | 2017 | 2893 | 0.410 |
Why?
|
Health Care Costs | 3 | 2023 | 3239 | 0.400 |
Why?
|
Medicine | 1 | 2020 | 945 | 0.400 |
Why?
|
Motivation | 2 | 2021 | 2020 | 0.380 |
Why?
|
Astrocytoma | 1 | 2016 | 774 | 0.370 |
Why?
|
Home Care Services | 1 | 2017 | 659 | 0.360 |
Why?
|
Spinal Fusion | 2 | 2017 | 1307 | 0.350 |
Why?
|
Sleep Apnea, Obstructive | 2 | 2022 | 1899 | 0.350 |
Why?
|
Cross-Sectional Studies | 13 | 2023 | 26375 | 0.340 |
Why?
|
Surgery, Computer-Assisted | 1 | 2017 | 1002 | 0.320 |
Why?
|
Costs and Cost Analysis | 3 | 2023 | 1666 | 0.320 |
Why?
|
Respiration, Artificial | 1 | 2020 | 2726 | 0.310 |
Why?
|
Piperazines | 1 | 2019 | 2552 | 0.310 |
Why?
|
United States | 19 | 2024 | 73027 | 0.300 |
Why?
|
Coronavirus Infections | 3 | 2020 | 3115 | 0.300 |
Why?
|
Retrospective Studies | 26 | 2023 | 81746 | 0.300 |
Why?
|
Pneumonia, Viral | 3 | 2020 | 3238 | 0.300 |
Why?
|
Lymph Nodes | 1 | 2019 | 3472 | 0.290 |
Why?
|
Humans | 67 | 2024 | 767991 | 0.290 |
Why?
|
Multiple Myeloma | 2 | 2015 | 5196 | 0.290 |
Why?
|
Papillomavirus Infections | 1 | 2019 | 1640 | 0.290 |
Why?
|
Telemedicine | 2 | 2022 | 3109 | 0.280 |
Why?
|
Ossification, Heterotopic | 2 | 2018 | 240 | 0.250 |
Why?
|
Databases, Factual | 2 | 2019 | 8082 | 0.250 |
Why?
|
Patient Acceptance of Health Care | 1 | 2017 | 3231 | 0.220 |
Why?
|
Insurance, Health | 3 | 2022 | 2517 | 0.220 |
Why?
|
Imaging, Three-Dimensional | 1 | 2017 | 4063 | 0.220 |
Why?
|
Fees and Charges | 1 | 2024 | 189 | 0.220 |
Why?
|
5-alpha Reductase Inhibitors | 1 | 2024 | 112 | 0.210 |
Why?
|
Kaplan-Meier Estimate | 3 | 2019 | 6517 | 0.200 |
Why?
|
Physicians | 1 | 2020 | 4598 | 0.200 |
Why?
|
Middle Aged | 25 | 2023 | 223422 | 0.200 |
Why?
|
Relative Value Scales | 2 | 2020 | 85 | 0.200 |
Why?
|
Outpatient Clinics, Hospital | 1 | 2024 | 392 | 0.200 |
Why?
|
Biological Products | 2 | 2022 | 948 | 0.200 |
Why?
|
Facial Nerve Injuries | 1 | 2022 | 64 | 0.200 |
Why?
|
Hospitals | 4 | 2023 | 3886 | 0.200 |
Why?
|
Cisplatin | 2 | 2019 | 1658 | 0.200 |
Why?
|
Male | 30 | 2024 | 364641 | 0.190 |
Why?
|
Female | 33 | 2024 | 397113 | 0.190 |
Why?
|
Voice Quality | 2 | 2020 | 226 | 0.190 |
Why?
|
Cosmetic Techniques | 1 | 2023 | 149 | 0.190 |
Why?
|
Lymphatic Metastasis | 2 | 2019 | 2908 | 0.180 |
Why?
|
Aged | 20 | 2023 | 171446 | 0.180 |
Why?
|
Hypersensitivity | 2 | 2021 | 1168 | 0.180 |
Why?
|
Adenoidectomy | 1 | 2022 | 171 | 0.180 |
Why?
|
Voice Training | 1 | 2020 | 44 | 0.180 |
Why?
|
Leuprolide | 1 | 2022 | 313 | 0.180 |
Why?
|
Legislation as Topic | 1 | 2020 | 76 | 0.180 |
Why?
|
Compensation and Redress | 1 | 2020 | 66 | 0.170 |
Why?
|
Olfactory Mucosa | 1 | 2021 | 101 | 0.170 |
Why?
|
Survival Rate | 3 | 2019 | 12828 | 0.170 |
Why?
|
Cautery | 1 | 2020 | 73 | 0.170 |
Why?
|
Fee Schedules | 1 | 2020 | 86 | 0.170 |
Why?
|
T-Lymphocytes | 2 | 2017 | 10264 | 0.170 |
Why?
|
Ambulatory Surgical Procedures | 1 | 2024 | 452 | 0.170 |
Why?
|
Hyaluronic Acid | 1 | 2023 | 484 | 0.170 |
Why?
|
Neoplasm Staging | 3 | 2019 | 11221 | 0.170 |
Why?
|
Otorhinolaryngologic Diseases | 1 | 2020 | 97 | 0.160 |
Why?
|
Baculoviridae | 1 | 2019 | 115 | 0.160 |
Why?
|
Anti-Anxiety Agents | 1 | 2022 | 405 | 0.160 |
Why?
|
Radiation Injuries | 2 | 2017 | 1198 | 0.160 |
Why?
|
Antineoplastic Agents | 2 | 2019 | 13658 | 0.160 |
Why?
|
Suction | 1 | 2020 | 268 | 0.160 |
Why?
|
Marketing of Health Services | 1 | 2020 | 151 | 0.160 |
Why?
|
Caspase 8 | 1 | 2019 | 198 | 0.160 |
Why?
|
Hair | 1 | 2022 | 508 | 0.160 |
Why?
|
Treatment Outcome | 10 | 2023 | 65364 | 0.150 |
Why?
|
Ambulatory Care Facilities | 1 | 2024 | 939 | 0.150 |
Why?
|
Cordotomy | 1 | 2018 | 7 | 0.150 |
Why?
|
TNF-Related Apoptosis-Inducing Ligand | 1 | 2019 | 195 | 0.150 |
Why?
|
Dysphonia | 1 | 2020 | 144 | 0.150 |
Why?
|
Rhinoplasty | 1 | 2022 | 241 | 0.150 |
Why?
|
Mammary Neoplasms, Experimental | 1 | 2020 | 506 | 0.150 |
Why?
|
Paranasal Sinuses | 1 | 2020 | 267 | 0.150 |
Why?
|
Cost Control | 1 | 2020 | 627 | 0.140 |
Why?
|
Failed Back Surgery Syndrome | 1 | 2017 | 21 | 0.140 |
Why?
|
Radiosurgery | 2 | 2017 | 1330 | 0.140 |
Why?
|
Nasopharynx | 1 | 2020 | 420 | 0.140 |
Why?
|
State Government | 1 | 2020 | 388 | 0.140 |
Why?
|
Radiation Tolerance | 1 | 2019 | 476 | 0.140 |
Why?
|
Access to Information | 1 | 2020 | 317 | 0.140 |
Why?
|
Temporal Bone | 2 | 2018 | 683 | 0.140 |
Why?
|
Medicare Part D | 1 | 2021 | 355 | 0.140 |
Why?
|
Laryngeal Diseases | 1 | 2020 | 248 | 0.130 |
Why?
|
Tongue | 1 | 2020 | 406 | 0.130 |
Why?
|
Cost Savings | 2 | 2021 | 904 | 0.130 |
Why?
|
Nasal Polyps | 1 | 2022 | 412 | 0.130 |
Why?
|
Nose | 1 | 2020 | 522 | 0.130 |
Why?
|
Cohort Studies | 6 | 2019 | 41749 | 0.130 |
Why?
|
Complex Regional Pain Syndromes | 1 | 2017 | 122 | 0.130 |
Why?
|
Neovascularization, Pathologic | 2 | 2017 | 2630 | 0.130 |
Why?
|
Laryngoscopy | 2 | 2020 | 714 | 0.130 |
Why?
|
Necrosis | 2 | 2017 | 1616 | 0.130 |
Why?
|
Cough | 1 | 2020 | 598 | 0.130 |
Why?
|
Postoperative Complications | 5 | 2018 | 15831 | 0.130 |
Why?
|
Quality-Adjusted Life Years | 1 | 2022 | 1741 | 0.130 |
Why?
|
Spondylolisthesis | 1 | 2017 | 173 | 0.120 |
Why?
|
Vocal Cords | 1 | 2020 | 520 | 0.120 |
Why?
|
Angiogenesis Inducing Agents | 1 | 2017 | 254 | 0.120 |
Why?
|
Gene Expression Regulation, Neoplastic | 3 | 2020 | 8637 | 0.120 |
Why?
|
Radiography | 2 | 2015 | 6983 | 0.120 |
Why?
|
Reimbursement Mechanisms | 1 | 2020 | 670 | 0.120 |
Why?
|
Vocal Cord Paralysis | 1 | 2018 | 275 | 0.120 |
Why?
|
Tomography, X-Ray Computed | 2 | 2018 | 20757 | 0.120 |
Why?
|
Surgical Flaps | 1 | 2023 | 1682 | 0.120 |
Why?
|
Cranial Irradiation | 1 | 2017 | 393 | 0.110 |
Why?
|
Prescription Drugs | 1 | 2021 | 635 | 0.110 |
Why?
|
Rhinitis | 1 | 2022 | 753 | 0.110 |
Why?
|
Radiotherapy, Adjuvant | 1 | 2019 | 1788 | 0.110 |
Why?
|
Xenograft Model Antitumor Assays | 2 | 2019 | 3609 | 0.110 |
Why?
|
Postoperative Care | 1 | 2020 | 1480 | 0.110 |
Why?
|
Immunomodulation | 1 | 2017 | 548 | 0.110 |
Why?
|
Pandemics | 4 | 2020 | 8748 | 0.110 |
Why?
|
Outpatients | 1 | 2021 | 1600 | 0.110 |
Why?
|
Bone Screws | 1 | 2017 | 534 | 0.110 |
Why?
|
Transforming Growth Factor beta | 2 | 2020 | 1996 | 0.110 |
Why?
|
Apoptosis | 3 | 2019 | 9521 | 0.110 |
Why?
|
Spinal Diseases | 1 | 2018 | 561 | 0.110 |
Why?
|
Neoplasms | 1 | 2022 | 22365 | 0.110 |
Why?
|
Patient Readmission | 2 | 2017 | 3288 | 0.110 |
Why?
|
Papillomaviridae | 1 | 2019 | 1140 | 0.110 |
Why?
|
Polysomnography | 1 | 2020 | 1869 | 0.100 |
Why?
|
Electrodes, Implanted | 1 | 2017 | 836 | 0.100 |
Why?
|
Delivery of Health Care | 2 | 2021 | 5366 | 0.100 |
Why?
|
Fluoroscopy | 1 | 2017 | 948 | 0.100 |
Why?
|
Sinusitis | 1 | 2022 | 997 | 0.100 |
Why?
|
Adult | 14 | 2023 | 223583 | 0.100 |
Why?
|
Linear Models | 2 | 2019 | 5884 | 0.100 |
Why?
|
Cardiology | 1 | 2023 | 1702 | 0.100 |
Why?
|
Information Dissemination | 1 | 2020 | 1142 | 0.100 |
Why?
|
Hyperglycemia | 1 | 2020 | 1388 | 0.100 |
Why?
|
Prosthesis Failure | 1 | 2017 | 1208 | 0.090 |
Why?
|
Propensity Score | 1 | 2019 | 1970 | 0.090 |
Why?
|
Facial Nerve | 2 | 2023 | 277 | 0.090 |
Why?
|
Pain Measurement | 2 | 2018 | 3583 | 0.090 |
Why?
|
Muscle, Smooth, Vascular | 1 | 2017 | 1495 | 0.090 |
Why?
|
Personnel Staffing and Scheduling | 1 | 2014 | 497 | 0.090 |
Why?
|
Cell Line, Tumor | 4 | 2020 | 17128 | 0.090 |
Why?
|
Hospitalists | 1 | 2014 | 298 | 0.090 |
Why?
|
Medical Staff, Hospital | 1 | 2014 | 602 | 0.090 |
Why?
|
Trauma Centers | 1 | 2016 | 951 | 0.090 |
Why?
|
Reoperation | 2 | 2017 | 4329 | 0.080 |
Why?
|
Spinal Cord Injuries | 1 | 2017 | 928 | 0.080 |
Why?
|
Hospitals, Pediatric | 2 | 2016 | 1874 | 0.080 |
Why?
|
Patient Satisfaction | 2 | 2023 | 3488 | 0.080 |
Why?
|
Body Height | 1 | 2015 | 1565 | 0.080 |
Why?
|
Disease-Free Survival | 1 | 2019 | 6843 | 0.080 |
Why?
|
Diabetes Complications | 1 | 2015 | 1319 | 0.080 |
Why?
|
Tumor Suppressor Protein p53 | 1 | 2019 | 2953 | 0.080 |
Why?
|
Antigens, Neoplasm | 1 | 2016 | 1997 | 0.080 |
Why?
|
Spine | 1 | 2015 | 1140 | 0.080 |
Why?
|
Medical Errors | 1 | 2017 | 1260 | 0.080 |
Why?
|
Disease Progression | 2 | 2015 | 13665 | 0.080 |
Why?
|
Patient Admission | 1 | 2016 | 1365 | 0.080 |
Why?
|
Cardiac Surgical Procedures | 1 | 2023 | 3683 | 0.070 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2019 | 4351 | 0.070 |
Why?
|
Patient Discharge | 2 | 2017 | 3476 | 0.070 |
Why?
|
Orthopedic Procedures | 1 | 2017 | 1279 | 0.070 |
Why?
|
Combined Modality Therapy | 1 | 2019 | 8535 | 0.070 |
Why?
|
Follow-Up Studies | 3 | 2018 | 39345 | 0.070 |
Why?
|
Prognosis | 2 | 2019 | 29979 | 0.070 |
Why?
|
Survival Analysis | 1 | 2019 | 10098 | 0.070 |
Why?
|
Attention Deficit Disorder with Hyperactivity | 1 | 2022 | 3729 | 0.070 |
Why?
|
Length of Stay | 2 | 2017 | 6495 | 0.070 |
Why?
|
Cell Proliferation | 2 | 2019 | 10470 | 0.070 |
Why?
|
Cadaver | 2 | 2020 | 1363 | 0.060 |
Why?
|
Brain Neoplasms | 2 | 2017 | 9116 | 0.060 |
Why?
|
Comorbidity | 2 | 2020 | 10590 | 0.060 |
Why?
|
Endothelium, Vascular | 1 | 2017 | 4427 | 0.060 |
Why?
|
Insurance Coverage | 1 | 2016 | 1946 | 0.060 |
Why?
|
Drug Synergism | 2 | 2019 | 1760 | 0.060 |
Why?
|
Prospective Studies | 3 | 2023 | 54924 | 0.050 |
Why?
|
Mice | 6 | 2020 | 82024 | 0.050 |
Why?
|
Smiling | 1 | 2023 | 71 | 0.050 |
Why?
|
Wounds and Injuries | 1 | 2016 | 2515 | 0.050 |
Why?
|
Predictive Value of Tests | 1 | 2019 | 15442 | 0.050 |
Why?
|
Smoking | 1 | 2019 | 9089 | 0.050 |
Why?
|
Denervation | 1 | 2023 | 265 | 0.050 |
Why?
|
DNA | 1 | 2015 | 7213 | 0.050 |
Why?
|
Middle Ear Ventilation | 1 | 2022 | 101 | 0.050 |
Why?
|
Referral and Consultation | 1 | 2014 | 3619 | 0.050 |
Why?
|
Inflammation | 1 | 2020 | 10871 | 0.050 |
Why?
|
Stroboscopy | 1 | 2020 | 62 | 0.040 |
Why?
|
Risk Assessment | 2 | 2019 | 24314 | 0.040 |
Why?
|
Emergency Service, Hospital | 2 | 2017 | 7939 | 0.040 |
Why?
|
Electrophysiologic Techniques, Cardiac | 1 | 2023 | 511 | 0.040 |
Why?
|
Brain | 2 | 2017 | 27366 | 0.040 |
Why?
|
Antigens, Differentiation, Myelomonocytic | 1 | 2020 | 283 | 0.040 |
Why?
|
Ohio | 1 | 2020 | 321 | 0.040 |
Why?
|
Disease Models, Animal | 4 | 2020 | 18344 | 0.040 |
Why?
|
Smell | 1 | 2021 | 260 | 0.040 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2019 | 11873 | 0.040 |
Why?
|
Animals | 6 | 2020 | 169222 | 0.040 |
Why?
|
Time Factors | 1 | 2019 | 40214 | 0.040 |
Why?
|
Karnofsky Performance Status | 1 | 2017 | 162 | 0.030 |
Why?
|
Perception | 1 | 2023 | 1209 | 0.030 |
Why?
|
Head | 1 | 2023 | 926 | 0.030 |
Why?
|
Drug Screening Assays, Antitumor | 1 | 2019 | 719 | 0.030 |
Why?
|
Risk Factors | 3 | 2020 | 74936 | 0.030 |
Why?
|
Otologic Surgical Procedures | 1 | 2018 | 148 | 0.030 |
Why?
|
Health Facilities | 1 | 2021 | 578 | 0.030 |
Why?
|
Drugs, Generic | 1 | 2021 | 455 | 0.030 |
Why?
|
Genes, erbB-2 | 1 | 2016 | 162 | 0.030 |
Why?
|
Particle Size | 1 | 2020 | 1649 | 0.030 |
Why?
|
District of Columbia | 1 | 2016 | 159 | 0.030 |
Why?
|
Chronic Disease | 2 | 2022 | 9384 | 0.030 |
Why?
|
Pregnancy | 1 | 2018 | 30260 | 0.030 |
Why?
|
Chick Embryo | 1 | 2017 | 975 | 0.030 |
Why?
|
Mice, Inbred C57BL | 3 | 2020 | 22381 | 0.030 |
Why?
|
Multivariate Analysis | 2 | 2018 | 12075 | 0.030 |
Why?
|
Antigen Presentation | 1 | 2019 | 1251 | 0.030 |
Why?
|
Osteotomy | 1 | 2018 | 838 | 0.030 |
Why?
|
Postoperative Period | 1 | 2017 | 1826 | 0.020 |
Why?
|
Logistic Models | 2 | 2018 | 13289 | 0.020 |
Why?
|
Host-Pathogen Interactions | 1 | 2021 | 1469 | 0.020 |
Why?
|
Gene Amplification | 1 | 2016 | 1088 | 0.020 |
Why?
|
Cells, Cultured | 2 | 2017 | 19017 | 0.020 |
Why?
|
Aged, 80 and over | 1 | 2015 | 59598 | 0.020 |
Why?
|
Antigens, CD | 1 | 2020 | 4035 | 0.020 |
Why?
|
Antidepressive Agents | 1 | 2022 | 2913 | 0.020 |
Why?
|
Massachusetts | 1 | 2022 | 8888 | 0.020 |
Why?
|
Spinal Cord | 1 | 2017 | 1811 | 0.020 |
Why?
|
Health Expenditures | 1 | 2022 | 2389 | 0.020 |
Why?
|
Cell Adhesion | 1 | 2015 | 3096 | 0.020 |
Why?
|
Disability Evaluation | 1 | 2015 | 1835 | 0.020 |
Why?
|
Particulate Matter | 1 | 2020 | 2617 | 0.020 |
Why?
|
Magnetic Resonance Imaging | 1 | 2015 | 36742 | 0.020 |
Why?
|
Regression Analysis | 1 | 2016 | 6339 | 0.020 |
Why?
|
Anxiety | 1 | 2022 | 4672 | 0.020 |
Why?
|
DNA Mutational Analysis | 1 | 2015 | 4114 | 0.020 |
Why?
|
Proto-Oncogene Proteins B-raf | 1 | 2016 | 2058 | 0.020 |
Why?
|
Macrophages | 1 | 2020 | 5799 | 0.020 |
Why?
|
Child | 3 | 2022 | 80906 | 0.020 |
Why?
|
Mice, Knockout | 1 | 2020 | 14486 | 0.020 |
Why?
|
Cell Movement | 1 | 2017 | 5209 | 0.020 |
Why?
|
Infant, Newborn | 2 | 2016 | 26420 | 0.010 |
Why?
|
Infant | 2 | 2016 | 36534 | 0.010 |
Why?
|
Prevalence | 1 | 2020 | 15867 | 0.010 |
Why?
|
Proportional Hazards Models | 1 | 2017 | 12536 | 0.010 |
Why?
|
Child, Preschool | 2 | 2016 | 42665 | 0.010 |
Why?
|
Depression | 1 | 2022 | 8231 | 0.010 |
Why?
|
Immunohistochemistry | 1 | 2015 | 11068 | 0.010 |
Why?
|
Boston | 1 | 2014 | 9368 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2018 | 15944 | 0.010 |
Why?
|
Young Adult | 2 | 2017 | 60048 | 0.010 |
Why?
|
Gene Expression Regulation | 1 | 2017 | 11930 | 0.010 |
Why?
|
Adenocarcinoma | 1 | 2016 | 6371 | 0.010 |
Why?
|
Melanoma | 1 | 2016 | 5706 | 0.010 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 1 | 2016 | 5394 | 0.010 |
Why?
|
Adolescent | 2 | 2016 | 89155 | 0.010 |
Why?
|
Hospitalization | 1 | 2014 | 10840 | 0.010 |
Why?
|
Signal Transduction | 1 | 2017 | 23642 | 0.010 |
Why?
|
Lung Neoplasms | 1 | 2016 | 13499 | 0.010 |
Why?
|
Breast Neoplasms | 1 | 2016 | 21206 | 0.000 |
Why?
|